Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sudarshan Sukhani of s2analytics.com is of the view that one can buy pharma stocks and prefers Wockhardt.
Ashish Kyal of wavesstrategy.com recommends buying Wockhardt and Jubilant Life Sciences.
Hemant Thukral of Aditya Birla Money is of the view that one can pick Aurobindo Pharma from the pharma space with a target of Rs 770-780.
Gaurav Bissa of LKP Securities is of the view that one may buy Mindtree with a target of Rs 1500.
Meghana V Malkan of malkansview.com is of the view that one may buy Ajanta Pharma with a target of Rs 1555.
According to Hemant Thukral of Aditya Birla Money, Wockhardt is a good traders pick and feels that it may test Rs 1550.
Rahul Mohindar of viratechindia.com recommends selling Wockhardt for a target of Rs 1100-1000.
Manas Jaiswal of manasjaiswal.com recommends selling Adani Ports with a target of Rs 300 and Wockhardt with a target of Rs 1100.
Sharmila Joshi, Market Expert advises buying KS Micro with a target of Rs 450.
Sudarshan Sukhani of s2analytics.com recommends buying Divis Laboratories and Wockhardt and adding Aurobindo Pharma.
Manav Chopra of Networth Stock Broking advises selling PTC India with a target of Rs 60.
According to Vishal Malkan of malkansview.com, one may hold Wockhardt.
Sharmila Joshi of sharmilajoshi.com is of the view that one may hold Wockhardt. "Tata Global Beverage may test Rs 175-180," she adds.
Sudarshan Sukhani of s2analytics.com recommends buying Dewan Housing Finance, Jubilant Foodworks and Wockhardt.
According to Hemant Thukral of Aditya Birla Money, Wockhardt may hit Rs 1625-1640 in the short term.
Dharmesh Kant of India Nivesh Securities is of the view that one may buy Sintex Industries with a target of Rs 124.
Rahul Mohindar of viratechindia.com recommends buying Hindustan Unilever, Wockhardt and Motherson Sumi Systems.
According to Kunal Bothra of LKP, one may buy Jubilant Life Sciences with a target of Rs 225.
Avinnash Gorakssakar of Precision Investment Services suggests buying Dish TV with a target of Rs 112.
Gaurav Bissa of LKP Securities recommends buying Wockhardt and advises selling Bank of India and Infosys.
Sameet Chavan of Angel Broking advises holding Wockhardt.
Sudarshan Sukhani of s2analytics.com is of the view that Wockhardt is in a downtrend and looks weak.
According to Market Expert, Shahina Mukadam, one may exit Wockhardt.
Sanju Verma of Violet Arc Global Managers is of the view that one may prefer Cadila Healthcare followed by Wockhardt and Cipla.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Wockhardt, United Spirits, ABG Shipyard, Ballarpur Industries, ITDC & Sun Pharma.